Zhi-Hong Jiang

Title: Zhi-Hong Jiang: Innovator in Cancer Treatment

Introduction

Zhi-Hong Jiang is a notable inventor based in Macau, China. He has made significant contributions to the field of cancer treatment through his innovative research and patent.

Latest Patents

Zhi-Hong Jiang holds a patent for "Nucleic acid molecules and uses thereof." This patent describes a method of treating subjects suffering from cancer by administering an effective amount of double-stranded RNA molecules. The RNA molecules are isolated or derived from bacteria of the genus. Additionally, the patent outlines a method for inhibiting the growth or proliferation of cancer cells by contacting these cells with the RNA molecule. It also includes a pharmaceutical composition for treating cancer that comprises the RNA molecule and a pharmaceutically tolerable excipient, along with a double-stranded RNA molecule and a recombinant vector.

Career Highlights

Zhi-Hong Jiang is affiliated with the Macau University of Science and Technology, where he continues to advance his research in the field of molecular biology and cancer treatment. His work has garnered attention for its potential impact on therapeutic strategies for cancer patients.

Collaborations

Zhi-Hong Jiang collaborates with notable colleagues, including Kai-Yue Cao and Yu Pan, who contribute to his research endeavors.

Conclusion

Zhi-Hong Jiang's innovative work in cancer treatment through his patented methods showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his research holds promise for future therapeutic developments.